Hotspots in NTRK2 or MAPKAPK2 are not present in bladder carcinoma but in other entities (Head-SCC, Lung-AdenoCA and Uterus-AdenoCA). This evidence concerns the gene NTRK2 and urinary bladder carcinoma.